11 November 2020 : Clinical Research
Serum Interleukin-6 Concentrations and the Severity of COVID-19 Pneumonia: A Retrospective Study at a Single Center in Bengbu City, Anhui Province, China, in January and February 2020
Hong Sun1CE, Pu Guo1BD, Lunjun Zhang1DF, Fengchao Wang1A*DOI: 10.12659/MSM.926941
Med Sci Monit 2020; 26:e926941
Table 3 Baseline demographic and clinical characteristics of patients with severe coronavirus disease-2019 (COVID-19).
| No. (%)Total (N=40) | Severe group A | General group B | p Value | |
|---|---|---|---|---|
| Sex | >0.05 | |||
| Female | 20 (50%) | 17 | 3 | |
| Male | 20 (50%) | 15 | 5 | |
| Age | 57.81±11.66 | 67.50±14.36 | <0.05 | |
| Comorbidities | ||||
| Diabetes | >0.05 | |||
| Hypertension | 1 (2.5%) | 1 | <0.05 | |
| Cardiovascular disease | ||||
| Interleukin-6 | 27.84±35.58 | 117.94±112.70 | <0.01 |